Business Description

Actavia Life Sciences Inc
NAICS : 325412 SIC : 2834
ISIN : US7538881068
Description
Actavia Life Sciences Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.08
Equity-to-Asset -80.92
Debt-to-Equity -0.11
Debt-to-EBITDA -0.05
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 24.71
9-Day RSI 35.66
14-Day RSI 40.77
6-1 Month Momentum % -61.5
12-1 Month Momentum % -58.82

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.01
Quick Ratio 0.01
Cash Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -123.7
Shareholder Yield % 0.84

Profitability Rank

Name Current Vs Industry Vs History
ROA % -8161.76
ROIC % -2084.56

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -1.45
EV-to-EBITDA -1.45
EV-to-FCF -113.87
Earnings Yield (Greenblatt) % -68.97
FCF Yield % -0.91

Financials

RASP's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:RASP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Actavia Life Sciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.008
Beta -110.25
Volatility % 358.73
14-Day RSI 40.77
14-Day ATR ($) 0.000137
20-Day SMA ($) 0.0077
12-1 Month Momentum % -58.82
52-Week Range ($) 0.0057 - 0.0319
Shares Outstanding (Mil) 771.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Actavia Life Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

Actavia Life Sciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Actavia Life Sciences Inc Frequently Asked Questions

What is Actavia Life Sciences Inc(RASP)'s stock price today?
The current price of RASP is $0.01. The 52 week high of RASP is $0.03 and 52 week low is $0.01.
When is next earnings date of Actavia Life Sciences Inc(RASP)?
The next earnings date of Actavia Life Sciences Inc(RASP) is .
Does Actavia Life Sciences Inc(RASP) pay dividends? If so, how much?
Actavia Life Sciences Inc(RASP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1